Currently, kidney transplantation is the best treatment option for kidney failure for a majority of eligible
patients. It is associated with a better quality of life and reduced mortality as compared to staying on dialysis.
Many of the improvements in kidney transplant outcomes, observed in recent decades, are due to more efficient
immunosuppression strategies. Therefore, developing expertise in the management of immunosuppressive drugs
is key to the success of kidney transplantation. In this review, the historical aspects of organ transplant immunosuppression
are briefly addressed and the basis of the allograft immune response to contextualize the main topic is
provided, which is a deeper view of the immunosuppressive agents, including their known mechanisms of action,
pharmacokinetics, interactions, toxicities, and clinical use. The most commonly used immunosuppressive protocols
employed based on patients' and donors' characteristics are also presented here.